产前遗传性热异形红细胞增多症的诊断与管理
遗传性热异形红细胞增多症(HPP)由SPTA1、SPTB、EPB41变异引起,可致胎儿贫血及水肿。产前诊断需先排除免疫性因素,结合血涂片形态与外显子测序,必要时用渗透脆性试验和伊红-5-马来酰亚胺流式细胞术鉴别。产前几乎均需宫内输血,新生儿期常依赖输血,脾切除可减轻部分患者输血需求,异基因干细胞移植(SCT)为新兴疗法。本文报告3例产前诊断并接受SCT的膜病患者,移植后均脱离输血且状况良好。
要点
- HPP由SPTA1、SPTB、EPB41变异导致,常引起胎儿贫血和水肿。
- 产前诊断需排除免疫性及其他非免疫性胎儿贫血原因。
- 诊断依靠特征性血涂片形态(最好用新鲜血标本)联合外显子测序。
核心结论
- HPP产前几乎均需宫内输血,新生儿期常依赖输血,脾切除可减轻部分患者输血需求,异基因干细胞移植为新兴疗法,本文3例移植后均脱离输血且状况良好。
研究设计与样本
- 本文为病例报告,报告3例产前诊断的膜病患者接受异基因干细胞移植。
主要发现
- 3例患者均产前诊断,产前和产后均需输血支持。
- 接受干细胞移植后,所有患者均脱离输血且状况良好。
关键数值与推荐
- 诊断采用特征性血涂片形态(最好用新鲜血标本)联合外显子测序。
- 当上述检查不确定时,渗透脆性试验和伊红-5-马来酰亚胺流式细胞术有助于鉴别HPP与其他膜病。
临床怎么用
- 产前诊断需先排除免疫性和其他非免疫性胎儿贫血原因。
- 产前几乎均需宫内输血。
- 新生儿期HPP持续引起严重贫血,患者通常依赖输血直至确定性干预。
- 部分患者脾切除可减轻或减少输血需求,另一些患者仍依赖输血,此反应可能与基因型相关。
- 异基因干细胞移植已在少数患者中实施且结果良好,作者报告3例移植后均脱离输血。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Hereditary pyropoikilocytosis (HPP) is a severe hemolytic anemia caused by variants in SPTA1, SPTB, and EPB41. These weaken horizontal interactions in the erythrocyte cytoskeleton, causing membrane fragmentation and splenic sequestration. It will readily cause fetal anemia and often hydrops fetalis. Prenatal diagnosis requires first ruling out immune and other non-immune causes of fetal anemia. Diagnosis is made using characteristic blood smear morphology, ideally examined on a native blood sample, paired with exome sequencing. When these are inconclusive, laboratory tests such as ektacytometry and eosin-5-maleimide flow cytometry can help distinguish HPP from other membranopathies. Prenatal disease almost always requires intrauterine transfusion. In the neonatal period, HPP will continue to cause severe anemia, and patients usually remain transfusion dependent until definitive intervention. For some patients, splenectomy relieves or reduces their transfusion requirements while others continue to be transfusion dependent. This response may be related to a patient's genotype. Allogeneic stem cell transplant (SCT) is an emerging therapy that has been performed in a few patients with good outcomes. We report three additional patients with membranopathy who have undergone SCT. All were diagnosed prenatally and required transfusion support pre- and post-natally. Following SCT, all patients became transfusion independent and are doing well.
引用
- Hartzell C, Stover S, Gibson N, et al. Diagnosis and Management of Prenatal Hereditary Pyropoikilocytosis. Prenat Diagn. 2025. PMID: 40714857. doi:10.1002/pd.6867
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。